| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |